Boundless Bio, Inc. (BOLD) stock
Close on Nov 11, 2026Market cap $55.96MP/E –Yield –
Boundless Bio statistics
61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.91
- 2.39
Share statisticsIndustry
- Shares Change (YoY)
- 0.84%
- 10.9%
- Shares Change (QoQ)
- 2.82%
- 0.51%
- Float
- 14M
- 49M
- Shares Held by Insiders
- 36.8%
- 11.6%
- Shares Held by Institutions
- 67.3%
- 56.4%
Short sellingIndustry
- Short Interest
- 790,294
- –
- Short Interest Change
- 0.23%
- -0.76%
- Short % of Float
- 5.49%
- 9.06%
- Short % of Shares Outstanding
- 3.47%
- 6.38%
- Days to Cover
- 5.06
- 5.16
Stock price statisticsIndustry
- 52-Week High
- $3.16
- –
- 52-Week Low
- $0.96
- –
- 20-Day Moving Average
- $2.42
- –
- 50-Day Moving Average
- $2.59
- –
- 200-Day Moving Average
- $1.96
- –
- Average True Range (14)
- $0.12
- –
- Price Change (1 Week)
- 2.50%
- -0.50%
- Price Change (1 Month)
- 1.23%
- -0.33%
- Price Change (3 Months)
- -11.4%
- -17.2%
- Price Change (6 Months)
- 59.7%
- -20.1%
- Price Change (YTD)
- 105.0%
- -20.1%
- Price Change (1 Year)
- 103.3%
- -19.3%
- Average Volume (10 Days)
- 71,587
- –
- Average Volume (20 Days)
- 126,394
- –
- Average Volume (90 Days)
- 169,857
- –
- Relative Volume
- 0.06
- 0.73
- Relative Strength Index (14)
- 48.2
- 47.6
- Volatility (1 Year)
- 98.9%
- 80.2%
- Beta (5 Years)
- 1.51
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -64.6%
- -51.3%
- Return on Assets (ROA)
- -47.8%
- -40.3%
- Return on Capital Employed (ROCE)
- -95.7%
- -37.7%
Financial positionIndustry
- Current Ratio
- 33.97
- 3.30
- Quick Ratio
- 33.60
- 2.37
EfficiencyIndustry
- Profits Per Employee
- -$1.98M
- -$680.86K
- Employee Count
- 28
- 75
- WACC
- 12.5%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $62.90M
- $16.31M
- Net Cash Per Share
- $2.77
- $0.70
- Equity (Book Value)
- $61.72M
- $53.12M
- Book Value Per Share
- $2.71
- $1.49
- Tangible Book Value
- $61.72M
- $26.11M
- Working Capital
- $61.72M
- $77.59M
Cash flow (TTM)Industry
- Capital Expenditures
- -$470.00K
- -$939.00K
- FCF Per Share
- -$2.52
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -99.2%
- -19.8%
- FCF Yield
- -102.6%
- -8.81%
Scores and fair valueIndustry
- Altman Z-Score
- 9.38
- 0.28
- Piotroski F-Score
- 3
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | BOLD | S&P 500 | Difference | BOLD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -2.8% | -2.4% | −0.4 pts | ||
| 3 months | -10.5% | -1.2% | −9.4 pts | ||
| Year to date | +105.0% | +12.3% | +92.7 pts | ||
| 1 year | +95.2% | +12.4% | +82.8 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M BOLD shares were sold short on Oct 30, 2026, up 0.2% from the previous report, or 5.49% of the shares available to trade. At recent volumes it would take 5.1 days to buy them back. Over the last 20 sessions, 29.1% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 790,294 | +0.2% | 156,210 | 5.1 |
| Oct 15, 2026 | 788,477 | +1.3% | 170,576 | 4.6 |
| Sep 30, 2026 | 778,470 | -4.1% | 183,184 | 4.3 |
| Sep 15, 2026 | 811,956 | -0.2% | 66,569 | 12.2 |
| Aug 31, 2026 | 813,286 | +18.0% | 115,442 | 7.0 |
| Aug 14, 2026 | 689,441 | +208.0% | 359,373 | 1.9 |
| Jul 31, 2026 | 223,819 | -6.9% | 147,209 | 1.5 |
| Jul 15, 2026 | 240,423 | +27.2% | 237,029 | 1.0 |
| Jun 30, 2026 | 188,948 | +637.4% | 6,600,590 | 1.0 |
| Jun 15, 2026 | 25,623 | +322.8% | 58,518 | 1.0 |
| May 29, 2026 | 6,060 | -76.7% | 78,897 | 1.0 |
| May 15, 2026 | 25,990 | +90.3% | 173,844 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?